Breast and Gynecologic Cancer Clinical Trials

Titlesort descending Intervention NCT ID Sponsor Status
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast Afimoxifene, Laboratory Biomarker Analysis, Placebo, Questionnaire Administration NCT03063619 M.D. Anderson Cancer Center Active, not recruiting
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II... Exemestane, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Quality-of-Life Assessment, Questionnaire Administration, Therapeutic Conventional Surgery NCT02598557 National Cancer Institute (NCI) Active, not recruiting
A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation Enhanced care, Potlako intervention NCT04141449 Brigham and Women's Hospital Recruiting
Connecting Families to Overcome Ovarian Cancer Message-based Outreach Intervention for Close Relatives, Message-based Outreach Intervention for Survivors, Standard Outreach for Close Relatives, Standard Outreach for Survivors NCT04927013 Emory University Recruiting
Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With... Recombinant Human Papillomavirus Nonavalent Vaccine NCT04265950 Fred Hutchinson Cancer Center Recruiting
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial... Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration NCT03300557 National Cancer Institute (NCI) Active, not recruiting
HPV-Based Screen-and-Treat Demonstration Project in Lilongwe VIA and thermocoagulation NCT04092257 UNC Lineberger Comprehensive Cancer Center Recruiting
HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration, Recombinant Human Papillomavirus Nonavalent Vaccine NCT03051516 Fred Hutchinson Cancer Center Active, not recruiting
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim, Surgical Procedure NCT02636582 National Cancer Institute (NCI) Active, not recruiting
Phase IIB Trial of Bazedoxifene Plus Conjugated Estrogens Bazedoxifene and Conjugated Estrogens NCT04821141 University of Kansas Medical Center Recruiting